Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Overview of Fungi01:29

Overview of Fungi

Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why intrinsic reduced susceptibility in rare fungal pathogens should be differentiated from intrinsic resistance: an ISHAM conceptual framework and narrative review.

Antimicrobial agents and chemotherapy·2026
Same author

Early Signal Without Clinical Cases: A Single Clade III <i>Candidozyma auris</i> Isolate from a Face Mask Highlights the Value of Environmental Quality Control.

Journal of fungi (Basel, Switzerland)·2026
Same author

Can voriconazole gradient diffusion testing results be extrapolated to isavuconazole and posaconazole in <i>Aspergillus</i> spp.? Comparative analysis with CLSI broth microdilution and <i>cyp51A</i> gene sequencing.

Antimicrobial agents and chemotherapy·2026
Same author

An automated workflow for fungal cell counting, cell size and data analysis: enhancing throughput and accuracy with the cell analysis and counting tool using ilastik software (caactus).

BMC microbiology·2026
Same author

Six-month surveillance of <i>Candida parapsilosis</i> in Tyrol, Austria: high-risk ST11 lineage and early, heterogeneous fluconazole resistance.

Frontiers in cellular and infection microbiology·2026
Same author

Closing the gap on antifungal resistance.

Nature medicine·2026

Related Experiment Video

Updated: Jun 1, 2026

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
09:27

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells

Published on: April 2, 2021

Caspofungin: when and how? The microbiologist's view.

Astrid Mayr1, Maria Aigner, Cornelia Lass-Flörl

  • 1Department of Hygiene, Microbiology and Social Medicine, Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria.

Mycoses
|June 15, 2011
PubMed
Summary

Caspofungin, an antifungal echinocandin, effectively treats fungal infections by inhibiting cell wall synthesis. However, resistance can occur, necessitating improved susceptibility testing for critical fungal pathogens.

More Related Videos

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
07:19

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

Published on: October 21, 2010

Related Experiment Videos

Last Updated: Jun 1, 2026

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
09:27

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells

Published on: April 2, 2021

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
07:19

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

Published on: October 21, 2010

Area of Science:

  • Mycology
  • Pharmacology
  • Infectious Diseases

Background:

  • Echinocandins, including caspofungin, are crucial antifungal agents targeting fungal cell wall synthesis.
  • Caspofungin exhibits broad-spectrum activity against Candida species and serves as an alternative for Aspergillus infections.
  • Its favorable safety profile makes it suitable for severe cases and specific patient populations.

Purpose of the Study:

  • To review the efficacy and resistance patterns of caspofungin.
  • To highlight the need for improved antifungal susceptibility testing methods.

Main Methods:

  • Literature review of caspofungin's in vitro and in vivo activity.
  • Analysis of reported breakthrough fungal infections and resistance mechanisms.
  • Discussion of current susceptibility testing guidelines.

Main Results:

  • Caspofungin demonstrates significant activity but resistance and breakthrough infections have been documented.
  • Mutations in the Fksp subunit of glucan synthase are linked to caspofungin resistance.
  • The specific pathogens and frequency of breakthrough mycoses require further delineation.

Conclusions:

  • Caspofungin remains a vital therapeutic option for serious fungal infections.
  • Enhanced in vitro susceptibility testing is needed to detect resistance mutations, particularly fks hot spot mutants.
  • Further research is required to fully understand and manage caspofungin resistance.